ADIPOQ and fatty liver disease: Our first major finding was that higher levels of proinflammatory biomarkers (ICAM-1, CRP, IL-6, and TNFαR2) and lower levels of the anti-inflammatory adiponectin were associated with fatty liver among HIV-uninfected men independent of VAT.